Julie Jordan serves as Executive at Homology Medicines, Inc., where they oversee executive responsibilities. Since joining the company, Julie Jordan has executed 10 insider transactions totaling $2.7K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 20, 2026 involved receiving (via award) 29,600 shares valued at $0.
Julie Jordan currently holds 29,600 shares of Homology Medicines, Inc. (FIXX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Julie Jordan has been a net seller of FIXX stock. They have purchased $0 and sold $2.7K worth of shares.
Julie Jordan's most recent insider trade was on Feb 20, 2026, when they sold 29,600 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Aug 3, 2023 | FIXX | $152 | Sale | 109 | $1.39 | Planned |
| Aug 3, 2023 | FIXX | $0 | Option Exercise | 387 | $N/A | Planned |
| Aug 3, 2023 | FIXX | $1.8K | Sale | 1,308 | $1.39 | Planned |
| Aug 3, 2023 | FIXX | $0 | Option Exercise | 1,548 | $N/A | Planned |
| Aug 3, 2023 | FIXX | $606 | Sale | 436 | $1.39 | Planned |
| Aug 3, 2023 | FIXX | $0 | Option Exercise | 4,644 | $N/A | Planned |
| Aug 2, 2023 | FIXX | $0 | Option Exercise | 350 | $N/A | Planned |
| Aug 2, 2023 | FIXX | $130 | Sale | 99 | $1.31 | Planned |